Polaris Group
Research Polaris Group (6550.TW) on Bullrun: market cap TWD 5.04B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6550.TW
- ExchangeTW
- CountryCayman Islands
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 5.04B
- Financial periodQ3 2026
- RevenueTWD 7.32M
- Net income-TWD 449.12M
- Free cash flow-TWD 482.54M
- Gross margin-1020.0%
Valuation Snapshot
latest market cap is TWD 5.04B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | TWD 40.60M | -TWD 3.93B | -TWD 3.19B | -665.8% | -9.82 | TWD 1.83B | TWD 2.35B | TWD 5.30B |
| FY2024 | TWD 107.00M | -TWD 2.50B | -TWD 3.69B | -71.9% | -6.45 | TWD 1.95B | TWD 1.88B | TWD 6.70B |
| FY2023 | TWD 7.48M | -TWD 1.49B | -TWD 1.59B | -41.0% | -3.87 | TWD 3.62B | TWD 1.20B | TWD 7.41B |
| FY2022 | TWD 6.44M | -TWD 1.15B | -TWD 1.10B | 22.0% | -3.02 | TWD 7.22B | TWD 382.62M | TWD 8.67B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-21 | TWD 5.04B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Polaris Group
Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands.
ETFs that hold Polaris Group
US-listed ETFs
Polaris Group is held by 8 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Vanguard ESG International Stock ETF (VSGX) | <0.01% | 0.10% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.01% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Polaris Group's market cap?
Polaris Group's market capitalization is TWD 5.04B.
What does Polaris Group do?
Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands.